| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4023041 | Journal Français d'Ophtalmologie | 2016 | 7 Pages |
Abstract
Intravitreal bevacizumab may be a beneficial approach for the management of large submacular hemorrhage secondary to AMD.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
R. Bouraoui, M. Bouladi, F. Kort, R. Limaiem, F. Mghaieth, L. El Matri,